BIODYNE HOLDING, S.A. sold 16.1% of their position (684.81K shares) of ENVVENO MEDICAL CORP on the open market
Open‑market sale worth $458.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/14/2020ACC: 0001493152-20-008635
10% Owner
Since May 2019
-684.81K
Net shares
Net seller
$458.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
684.81K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−684.81K
Price / share
$0.67
Trade value
$458.82K
% of position
16.1%
6/7/2019
4.27M→3.58M
Total
Net shares
−684.81K
Net value
-$458.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/7/2019 | S · Sale | −684.81K | $0.67 | $458.82K | 16.1% | 4.27M | 3.58M |
| Total | −684.81K | -$458.82K | ||||||
Derivative Transactions0
No derivative transactions reported